Back to drug list

Monoferric (ferric derisomaltose)


Billing

Code: J1437

Description: Inj. fe derisomaltose 10 mg

Unit: 10 mg

Payment: $20.059

Pay quarter: Q4 2023


Medicare history

Dosage and Frequency

Iron Deficiency Anemia (IDA)

• 1000mg IV if patient weighs 50kg or more
• 20mg/kg IV if patient weighs less than 50kg

Calculate drug reimbursement


Total Reimbursement:

$2,005.90

(ASP: $1,892.36, Margin: $113.54)


Code:

J1437

# Units to bill:

100

Prior Authorization

Prior auth criteria for Monoferric may include but is not limited to:


1. The patient must have iron deficiency anemia (IDA) that is confirmed by laboratory testing.

2. The patient must have an absolute deficiency of iron, as demonstrated by a ferritin level less than or equal to 30 ng/mL or an iron saturation less than or equal to 20%.

3. The patient must have failed or cannot tolerate oral iron therapy.

4. The patient must not have any contraindications to the use of intravenous iron therapy, including known hypersensitivity to Monoferric or any of its components.

5. The patient must not have received an intravenous iron product within the last 8 weeks prior to treatment.

6. The patient must meet the criteria for any applicable cost-sharing, such as copayments and deductibles.


Insurance prior auth guidelines:

Aetna

United Healthcare

Anthem

Cigna


Billable NDCs

73594-9310-01

Monoferric (PHARMACOSMOS THERAPEUTICS)

1000 MG



Resources

Website